Images List Premium Download Classic

Inflammatory Disease

Inflammatory Disease-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Novel compounds
Glaxosmithkline Intellectual Property Development Limited
May 17, 2018 - N°20180134688

The present invention relates to compounds, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, for example as inhibitors of the activity of rip2 kinase, including degrading rip2 kinase, the treatment of diseases and conditions mediated by the rip2 kinase, in particular for ...
NEW 1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinase ...
Respivert Limited
May 17, 2018 - N°20180134687

There is provided a compound of formula (i) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and copd.
NEW Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
Tes Pharma S.r.i.
May 17, 2018 - N°20180134667

The present disclosure discloses compounds capable of modulating the activity of α-amino-β-carboxymuconic acid semialdehyde decarboxylase (acmsd), which are useful for the prevention and/or the treatment of diseases and disorders associated with defects in nad+ biosynthesis, e. G., metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and diseases associated with ageing. The present application ...
NEW Inflammatory Disease Patent Pack
Download 291+ patent application PDFs
Inflammatory Disease Patent Applications
Download 291+ Inflammatory Disease-related PDFs
For professional research & prior art discovery
inventor
  • 291+ full patent PDF documents of Inflammatory Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
Abbott Laboratories
May 17, 2018 - N°20180133235

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
NEW Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
Abbott Laboratories
May 17, 2018 - N°20180133234

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
NEW Method of treating inflammation using natural compounds and/or diet
University Of Florida Research Foundation, Incorporated
May 17, 2018 - N°20180133194

The current invention is directed to a treatment of an inflammatory disease comprising administering to a subject in need of such treatment a composition comprising epigallocatechin-3-gallate (egcg), curcumin, glucosinolates and/or derivatives thereof and medium chain triglycerides and, optionally, providing a ketogenic diet or a modified ketogenic diet to the subject. In an embodiment, the inflammatory disease is increased ...
NEW Inflammatory Disease Patent Pack
Download 291+ patent application PDFs
Inflammatory Disease Patent Applications
Download 291+ Inflammatory Disease-related PDFs
For professional research & prior art discovery
inventor
  • 291+ full patent PDF documents of Inflammatory Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases
Ab2 Bio Sa
May 10, 2018 - N°20180127494

The present invention provides means and methods for treating interleukin 18 (il-18)-associated diseases and disorders, in particular, the present invention discloses antibodies specific for free il-18 and il-18 binding protein (il-18bp) for use in such treatments and for the diagnosis of the diseases and disorders.
Novel cholesterol metabolite, 5-cholesten, 3beta-25-diol, disulfate (25hcds) for therapy of metabolic disorders, hyperlipidemia, diabetes, ...
Virginia Commonwealth University
May 10, 2018 - N°20180127457

5-cholesten, 3β,25-diol, disulfate (25hcds) has been found to be an authentic pparγ agonist and lxr antagonist, and is used for the therapy of lipid disorders and inflammatory diseases, including without limitation fatty liver, inflammatory bowel, and atherosclerotic diseases.
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
May 10, 2018 - N°20180127425

Wherein r1a, r1b, r2, r4, r5, r6, r7, r8, w, x, y, z, cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (npp2 or enpp2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving ...
Serine/threonine kinase inhibitors
Genentech, Inc.
May 10, 2018 - N°20180127393

Compounds of formula i or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative, pain and inflammatory diseases. Methods of using compounds of formula i or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders ...
Tert-butyl n-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2h)-yl]-3,5- difluorophenyl}ethyl]...
Macrophage Pharma Limited
May 10, 2018 - N°20180127371

The present invention provides a compound which is: tert-butyl n-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2h)-yl]-3,5-difluorophenyl}ethyl)-l-alaninate or a salt, hydrate or solvate thereof. The present invention also provides a pharmaceutical composition comprising the compound together with one or more pharmaceutically acceptable carriers and/or excipients. The compound and composition are useful for inhibiting ...
Glucocorticoid receptor agonist and immunoconjugates thereof
Abbvie Inc.
May 10, 2018 - N°20180126000

Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e. G., to treat autoimmune or inflammatory diseases.
Virus-like particle with efficient epitope display
University Of Copenhagen
May 10, 2018 - N°20180125954

The invention relates to a virus-like particle (vlp) based vaccine. The virus-like particle constitutes a non-naturally occurring, ordered and repetitive antigen array display scaffold which can obtain a strong and long-lasting immune response in a subject. The vlp-based vaccine may be used for the prophylaxis and/or treatment of a disease including, but is not limited to, cancer, cardiovascular, infectious, ...
Inflammatory Disease Patent Pack
Download 291+ patent application PDFs
Inflammatory Disease Patent Applications
Download 291+ Inflammatory Disease-related PDFs
For professional research & prior art discovery
inventor
  • 291+ full patent PDF documents of Inflammatory Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and methods to accelerate resolution of acute lung inflammation
The Johns Hopkins University
May 10, 2018 - N°20180125874

The present invention provides methods and compositions for treatment of acute inflammatory diseases or disorders and/or for treatment of lung injury. Certain exemplary methods involve administering an il-4 polypeptide or fragment thereof possessing cytokine activity or an il-4 agonist systemically to a subject having an inflammatory disease or disorder and/or a lung injury. Other exemplary methods involve administering ...
Reducing systemic regulatory t cell levels or activity for treatment of alzheimer's disease
Yeda Research And Development Co. Ltd.
May 03, 2018 - N°20180118826

A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the cns that does not include the autoimmune neuroinflammatory disease, relapsing-remitting multiple sclerosis (rrms), is provided. The pharmaceutical composition is for administration by a dosage regimen comprising at least two ...
Compounds
May 03, 2018 - N°20180118754

And to compositions comprising the same and to the use of the compounds and their compositions in treatment, for example in the treatment of inflammatory diseases, in particular respiratory inflammatory disease. The invention also extends to methods of making said compounds.
New compounds i
May 03, 2018 - N°20180118744

And their pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers, tautomers, optical isomers or n-oxides, which are inhibitors of ssao activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment of medical conditions wherein inhibition of ssao activity is beneficial, such as inflammatory diseases and immune disorders.
Lap e3 ligase directed proteolysis targeting chimeric molecules
Glaxosmithkline Intellectual Property Development Limited
May 03, 2018 - N°20180118733

The present invention relates to compounds, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, for example as inhibitors of the activity of rip2 kinase, including degrading rip2 kinase, the treatment of diseases and conditions mediated by the rip2 kinase, in particular for ...
Pyrazolyl ureas as kinase inhibitors
Respivert Limited
May 03, 2018 - N°20180118719

There are provided compounds of formula (i) as defined in the specification which are p38 map kinase inhibitors for use as medicaments for the treatment inter alia of inflammatory diseases.
Novel compound having immune disease treatment effect and use thereof
The Catholic University Of Korea Industry-academic Cooperation Foundation
May 03, 2018 - N°20180118668

The present invention relates to a novel compound capable of effectively preventing and treating immune diseases and a use thereof. The novel compound of the present invention has effects of inhibiting the production of inflammatory cytokines, increasing the activity of regulatory t cells having immunoregulatory functions, inhibiting the production of auto-antibodies to regulate excessive immune responses, and inhibiting the differentiation ...
Substituted hydroxystilbenes and their therapeutic applications
Resolvex Pharmaceuticals Inc.
May 03, 2018 - N°20180118667

It discloses a compound of formula i that inhibits the activities of numerous of protein kinases involving the signaling of inflammatory cytokines, therefore, the compound can be used for treating cancers, autoimmune diseases and inflammatory diseases.
Loading